Viridian Therapeutics Inc (VRDN)
$18.98 -$0.24 (-1.24%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.56B -
Day's Range
$18.88 - $19.54 -
Volume
963,709 -
52 Week Low / High
$11.40 - $27.20 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 10
- Strong Buy
- 5
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $43.53
- Target Price
Company News
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
-
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc — Oct 18th, 2024
Overview of the Recent Trade On September 30, 2024, State Street Corp executed a significant transaction involving Viridian Therapeutics Inc (NASDAQ:VRDN), a key player in the biopharmaceutical industry. The firm reduced its holdings by 392,605 shares, with the transaction priced at $22.7...
Similar Stocks
Portfolio
Comprised of 1 portfolios